The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
STRO · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | DAIO | STRO | LH | QURE |
|---|---|---|---|---|
| Moat Score (0–100) | 39 | 40 (highest) | 39 | 39 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 16 | 60 (highest) | 38 | 15 |
| Pricing power | 91 | — | 43 | 96 (highest) |
| Returns on capital | 11 | 0 | 19 (highest) | 7 |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 32 | 55 (highest) |
| Capital allocation | 24 | 44 | 65 (highest) | 24 |
| No price data | No price data | 95% above value if growth stopped today | No price data | |
| Market cap | $29.3M | $196M | $24.4B | $2.4B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |